Latest Lead News

Panther Metals has completed a $315k shortfall placement, bolstering its funding as it plans deeper drilling at Burtville East and initiates a strategic review of its Coglia project in response to soaring cobalt prices.

Racura Oncology has appointed Beyond Drug Development to oversee its HARNESS-1 Phase 1a/b trial combining RC220 with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward clinical advancement.

EPX Limited has successfully completed a $2.14 million private placement to institutional investors, positioning itself to acquire Wattwatchers Pty Limited and invest in new technology initiatives. An upcoming Share Purchase Plan will offer existing shareholders further participation opportunities.

Adherium Limited has exceeded its 2025 shipment goals by delivering over 4,600 Hailie® Smartinhaler® devices, including more than 2,000 to Remote Patient Monitoring patients, signaling robust operational momentum.

EVT Limited has acquired the premium QT Auckland hotel for NZ$87.5 million, reinforcing its strategic presence in key city markets while divesting non-core assets to focus on high-performing properties.

Dimerix secures FDA confirmation that proteinuria reduction is a valid primary endpoint for its Phase 3 ACTION3 trial, advancing its kidney disease drug DMX-200 closer to approval.

Big River Industries has successfully completed a $10 million entitlement offer, oversubscribed by shareholders, to partly fund its acquisition of Johns Building Supplies in Western Australia.

Celsius Resources has postponed the final Feasibility Study for its Maalinao-Caigutan-Biyog Copper-Gold Project to January 2026, while engaging a top financial advisory firm to secure project financing amid strong international interest.

Nutritional Growth Solutions announces the departure of CEO Stephen J. Turner, appointing Non-Executive Director Andrew Grover as interim CEO to steer the company through its next phase.

ActivEX Limited has completed a $100,000 share placement with Business Victor Investments Limited, aiming to accelerate its exploration activities and strengthen working capital.

Australian Ethical Investment Ltd has released its 2026 reporting calendar, outlining important dates for financial disclosures, dividends, and corporate governance events.

The FDA’s recent ruling classifying traditionally prepared kava beverages as food under U.S. law clears a major regulatory hurdle for The Calmer Co, accelerating its growth on Amazon and strengthening its U.S. expansion strategy.